Liam CK, Ahmad AR, Hsia TC, Zhou J, et al. Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis. Clin Cancer Res 2023;29:1879-1886.
PMID: 36971777